All News about Gamida Cell Ltd
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Gamida Cell to Present Corporate Highlights at 2022 Cell & Gene Meeting on the Mesa
October 10, 2022
From Gamida Cell Ltd.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/10/05/image28.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220929005316/en/1586798/5/Gamida-Cell-Logo_Sept2022.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_809.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/29/image_6.jpg?width=1200&height=800&fit=crop)
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
September 29, 2022
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/28/image24.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/28/image16.jpg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares
September 28, 2022
From Gamida Cell
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Gamida Cell Announces Launch of Public Offering of Ordinary Shares
September 27, 2022
From Gamida Cell Ltd.
Via Business Wire
![](https://mms.businesswire.com/media/20220919005300/en/1575286/5/Lyndra-Corporate-Shoot-Abbey_J_0290_20220728_%28002%29.jpg)
![](https://mms.businesswire.com/media/20220912005342/en/1567928/5/Gamida-Cell-Logo_Sept2022.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8423.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/12/image_7.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/01/bz-pharma_8.jpg?width=1200&height=800&fit=crop)
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 01, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/01/bz-pharma_3.jpg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13166.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13265.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/06/16/premkt_movers.png?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20220610005046/en/1482534/4/gamida_logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.